User:Syed Hassan Abbas Kazmi: Difference between revisions
Jump to navigation
Jump to search
(20 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Syed | ==Syed Kazmi== | ||
Contact: <br /> | Contact: <br /> | ||
Email: [mailto:hassankazmi@kemu.edu.pk, skazmi@bidmc.harvard.edu]<br /> | Email: [mailto:hassankazmi@kemu.edu.pk, skazmi@bidmc.harvard.edu]<br /> | ||
==Current Position== | ==Current Position== | ||
*Associate Editor-in-Chief, WikiDoc.org<br> | *Associate Editor-in-Chief, WikiDoc.org<br> | ||
*Postdoctoral Research Fellow, PERFUSE Study Group | *Postdoctoral Research Fellow, PERFUSE Study Group | ||
* | |||
* | |||
==Authored Pages== | ==Authored Pages== | ||
Line 36: | Line 20: | ||
* [[Dermatophytosis]] | * [[Dermatophytosis]] | ||
* [[Whipworm infection]] | * [[Whipworm infection]] | ||
{{ColBreak}} | |||
* [[Bourbon virus infection]] | * [[Bourbon virus infection]] | ||
* [[Sleep deprivation survey]] | * [[Sleep deprivation survey]] | ||
Line 44: | Line 29: | ||
* [[Nephrolithiasis]] | * [[Nephrolithiasis]] | ||
* [[Hematuria]] | * [[Hematuria]] | ||
{{ColBreak}} | |||
* [[Venous thromboembolism|Venous Thromboembolism]] | * [[Venous thromboembolism|Venous Thromboembolism]] | ||
* [[Down syndrome|Down's Syndrome]] | * [[Down syndrome|Down's Syndrome]] | ||
Line 53: | Line 39: | ||
* [[Deep vein thrombosis medical therapy]] | * [[Deep vein thrombosis medical therapy]] | ||
* Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018) | * Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018) | ||
{{ColBreak}} | |||
* [https://cardiologynownews.org/corevalve-evolut-r-and-edwards-sapien-3-valves-reveal-equivalence-in-transcatheter-aortic-valve-implantation-tavi-in-a-head-to-head-comparison/ Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison] | * [https://cardiologynownews.org/corevalve-evolut-r-and-edwards-sapien-3-valves-reveal-equivalence-in-transcatheter-aortic-valve-implantation-tavi-in-a-head-to-head-comparison/ Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison] | ||
* [https://cardiologynownews.org/polymer-coated-sustained-release-eluvia-des-outshines-non-polymer-coated-zilver-des-for-femoropopliteal-artery-stenosis/ Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis] | * [https://cardiologynownews.org/polymer-coated-sustained-release-eluvia-des-outshines-non-polymer-coated-zilver-des-for-femoropopliteal-artery-stenosis/ Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis] | ||
* [https://cardiologynownews.org/dual-therapy-reduces-bleeding-compared-with-triple-therapy-in-a-fib-after-pci/ Dual Therapy Reduces Bleeding Compared with Triple Therapy in A-Fib after PCI] | * [https://cardiologynownews.org/dual-therapy-reduces-bleeding-compared-with-triple-therapy-in-a-fib-after-pci/ Dual Therapy Reduces Bleeding Compared with Triple Therapy in A-Fib after PCI] | ||
*[https://cardiologynownews.org/lowest-is-best-when-it-comes-to-blood-ldl-cholesterol-levels/ ‘Lowest is best’ when it comes to blood LDL cholesterol levels (A meta-analysis shows lower blood LDL cholesterol levels may be efficacious and safe)] | *[https://cardiologynownews.org/lowest-is-best-when-it-comes-to-blood-ldl-cholesterol-levels/ ‘Lowest is best’ when it comes to blood LDL cholesterol levels (A meta-analysis shows lower blood LDL cholesterol levels may be efficacious and safe)] | ||
{{ColBreak}} | |||
* [https://cardiologynownews.org/deciphering-the-underpinnings-of-minoca-mi-with-non-obstructive-coronary-arteries/ Deciphering the Underpinnings of MINOCA (MI with Non-Obstructive Coronary Arteries)] | |||
* [https://cardiologynownews.org/novel-target-for-cardiovascular-outcomes-cholesterol-efflux-capacity-inversely-associated-with-all-cause-mortality/ Novel Target For STEMI Patients: Cholesterol Efflux Capacity Inversely Associated with All-Cause Mortality] | |||
{{EndMultiCol}} | |||
== Reviewed Pages == | |||
{{Multicol}} | |||
* [[Cryptococcus infection]] | |||
* [[Fibromyalgia]] | |||
* [[Trypanosomiasis]] | |||
* [[Chickenpox]] | |||
* [[Systemic lupus erythematosus|Lupus]] | |||
* [[Bronchiolitis]] | |||
* [[Pheochromocytoma]] | |||
* [[Prolactinoma]] | |||
* [[Pituitary apoplexy]] | |||
* [[Syndrome of inappropriate antidiuretic hormone|SIADH]] | |||
{{ColBreak}} | |||
* [[Protein energy malnutrition|Protein-energy malnutrition]] | |||
* [[Thyroid nodule]] | |||
* [[Hyperosmolar hyperglycemic state|Hyperosmolar hyperglycemic syndrome]] | |||
* [[Autoimmune polyendocrine syndrome]] | |||
* [[Hirsutism]] | |||
* Hypocalciuric hypercalcemia | |||
* [[Hypoparathyroidism]] | |||
* [[Hypopituitarism]] | |||
* [[Gastroparesis]] | |||
* [[Budd Chiari syndrome]] | |||
{{ColBreak}} | |||
* [[Zenker diverticulum]] | |||
* [[Stomach cancer]] | |||
* [[Irritable bowel syndrome]] | |||
* [[Short bowel syndrome]] | |||
* [[Gastric dumping syndrome|Dumping syndrome]] | |||
* [[Cholangitis]] | |||
* [[Cirrhosis]] | |||
* [[Intussusception|Intusussception]] | |||
* [[Transjugular intrahepatic portosystemic shunt|TIPS]] | |||
* [[Hepatocellular carcinoma]] | |||
{{ColBreak}} | |||
* [[Dyspepsia]] | |||
* [[Ileus]] | |||
* [[Acute diarrhea classification|Acute diarrhea]] | |||
* [[Femoral hernia]] | |||
* [[Oral cancer]] | |||
* [[Small cell lung cancer]] | |||
* [[Pneumonia]] | |||
* [[Adenocarcinoma]] | |||
* [[Respiratory failure]] | |||
* [[Rabies]] | |||
{{EndMultiCol}} | {{EndMultiCol}} | ||
<br style="clear:left"> | |||
== Languages == | |||
'''English:''' Fluent in reading, writing and speaking | |||
'''Urdu''': Fluent in reading, writing and speaking | |||
'''Hindi:''' Fluent in speaking | |||
'''Punjabi:''' Fluent in reading, writing and speaking | |||
'''Arabic:''' Fluent in reading and writing | |||
'''Persian''': Fluent in reading and writing | |||
<br style="clear:left"> |
Latest revision as of 06:05, 13 January 2025
Syed Kazmi
Contact:
Email: skazmi@bidmc.harvard.edu
Current Position
- Associate Editor-in-Chief, WikiDoc.org
- Postdoctoral Research Fellow, PERFUSE Study Group
Authored Pages
Reviewed Pages
Languages
English: Fluent in reading, writing and speaking
Urdu: Fluent in reading, writing and speaking
Hindi: Fluent in speaking
Punjabi: Fluent in reading, writing and speaking
Arabic: Fluent in reading and writing
Persian: Fluent in reading and writing